PHC9 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN THE UK
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66763-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)66763-0/fulltext
Section Title :
Section Order :
600
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66763-0&doi=10.1016/S1098-3015(10)66763-0